Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Phenylketonuria (PKU) and Hyperphenylalaninemia”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 0 results

Not applicableStudy completedNCT01924026
What this trial is testing

Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study

Who this might be right for
PhenylketonuriaMild Hyperphenylalaninemia
The Hospital for Sick Children 10
Not applicableStudy completedNCT04375592
What this trial is testing

Acceptability and Tolerance of a Ready-to-use Protein Substitute in Tablet Form for the Dietary Management of Phenylketonuria

Who this might be right for
PhenylketonuriasHyperphenylalaninaemiaTetrahydrobiopterin Deficiency
metaX Institut fuer Diatetik GmbH 10
Not applicableLooking for participantsNCT07551921
What this trial is testing

PheCheck™ Validation Study

Who this might be right for
Phenylketonuria (PKU) and Hyperphenylalaninemia
Aptatek BioSciences, Inc 60
Not applicableStudy completedNCT03864029
What this trial is testing

Retrospective Observational Safety Effectiveness With Kuvan in hpA

Who this might be right for
Tetrahydrobiopterin Deficiency
BioMarin Pharmaceutical 26
Not applicableStudy completedNCT01869972
What this trial is testing

Biological Variation of Phenylalanine in Patients With Hyperphenylalaninemia

Who this might be right for
PhenylketonuriaHyperphenylalaninemia
Hamilton Health Sciences Corporation 32
Not applicableStudy completedNCT01016392
What this trial is testing

Observational Study on the Long Term Safety of Kuvan® Treatment in Patients With Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or BH4 Deficiency

Who this might be right for
Hyperphenylalaninemia (HPA) Due to Phenylketonuria (PKU) or Tetrahydrobiopterin (BH4) Deficiency
BioMarin Pharmaceutical 627
Testing effectiveness (Phase 2)Study completedNCT03519711
What this trial is testing

PTC923 (CNSA-001) in Primary Tetrahydrobiopterin (BH4) Deficient Participants With Hyperphenylalaninemia

Who this might be right for
BH4 DeficiencyHyperphenylalaninemia
PTC Therapeutics 8